Bioventus, Inc. (BVS)
9.95
-0.67
(-6.31%)
USD |
NASDAQ |
Nov 19, 16:00
9.96
+0.01
(+0.10%)
After-Hours: 20:00
Bioventus Shareholders Equity (Quarterly) : 240.50M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 240.50M |
| June 30, 2026 | 228.31M |
| March 31, 2026 | 188.90M |
| December 31, 2025 | 184.10M |
| September 30, 2025 | 166.10M |
| June 30, 2025 | 161.24M |
| March 31, 2025 | 148.14M |
| December 31, 2024 | 147.94M |
| September 30, 2024 | 148.74M |
| June 30, 2024 | 150.94M |
| March 31, 2024 | 171.28M |
| December 31, 2023 | 173.59M |
| September 30, 2023 | 177.53M |
| June 30, 2023 | 183.20M |
| March 31, 2023 | 188.51M |
| December 31, 2022 | 325.24M |
| September 30, 2022 | 343.40M |
| June 30, 2022 | 447.98M |
| March 31, 2022 | 449.78M |
| December 31, 2021 | 458.92M |
| September 30, 2021 | 152.50M |
| June 30, 2021 | 141.56M |
| Date | Value |
|---|---|
| March 31, 2021 | 142.39M |
| December 31, 2020 | 142.24M |
| September 30, 2020 | 143.22M |
| June 30, 2020 | 139.18M |
| March 31, 2020 | |
| December 31, 2019 | 142.98M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | 186.30M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Accuray, Inc. | 53.12M |
| Orthofix Medical, Inc. | 429.57M |
| ResMed, Inc. | 5.948B |
| Rockwell Medical, Inc. | 33.14M |
| Microbot Medical, Inc. | 63.45M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 673.43M |
| Total Liabilities (Quarterly) | 381.56M |
| Debt to Equity Ratio | 1.015 |
| Current Ratio | 1.684 |
| Net Debt Paydown Yield | 2.50% |